sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Global Therapeutic Nuclear Medicines Market Growth 2019-2024

Global Therapeutic Nuclear Medicines Market Growth 2019-2024

Home / Categories / Healthcare
Global Therapeutic Nuclear Medicines Market Growth 2019-2024
Global Therapeutic Nuclear Medicines Market...
Report Code
RO1/109/3526

Publish Date
07/May/2019

Pages
165
PRICE
$ 3660/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 5490/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 7320/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
North Americas is the largest consumption place, with a revenue market share nearly 44.8% in 2018. Following North Americas, Europe is the second largest consumption place with the revenue market share of 29% in 2018.

According to this study, over the next five years the Therapeutic Nuclear Medicines market will register a 18.7% CAGR in terms of revenue, the global market size will reach US$ 1968.7 million by 2024, from US$ 836.4 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Therapeutic Nuclear Medicines business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Therapeutic Nuclear Medicines market by product type, application, key manufacturers and key regions and countries.

This study considers the Therapeutic Nuclear Medicines value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Radium-223
Lutetium-177
Iodine-131
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Thyroid
Bone Metastasis
Lymphoma
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bayer
Novartis AG
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Therapeutic Nuclear Medicines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Therapeutic Nuclear Medicines market by identifying its various subsegments.
Focuses on the key global Therapeutic Nuclear Medicines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Therapeutic Nuclear Medicines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Therapeutic Nuclear Medicines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com